INSIGHTS ON QUALITY CONTROL
-
Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Presentation
Maintaining high-purity water is vital for pharmaceutical production. Explore key strategies for system design, risk mitigation, and rigorous process control to ensure consistent regulatory compliance.
-
FDA's Risk-Based Inspection Shift: What It Actually Rewards
FDA’s revised pre-approval inspection program prioritizes risk-based determinations over routine site visits. Review risk assessment factors and transition toward continuous audit readiness.
-
Physical Contamination Detection
Learn how physical contaminants enter production lines and how detection systems like metal detection and X-ray inspection help prevent defects and recalls to strengthen quality control.
-
Capsule Checkweigher Software Functions
Strengthen data integrity and 21 CFR Part 11 compliance. Discover how advanced software features, automated lot controls, and secure network integration protect your production line.
-
Aggregate Analysis Of Tirzepatide12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Predicting Drug-Loading Limits In Tablet Formulations7/15/2026
Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.
-
Designing An Environmental Monitoring Solution For GMP Applications3/5/2026
Implement robust contamination control strategies that align with current regulatory requirements. Optimize your environmental monitoring framework through precise design and data-driven analysis.
-
Science With Purpose: Advancing Sustainability In Biopharma Testing6/9/2026
Learn how biopharma labs are cutting animal use, energy, and paper waste while maintaining GMP compliance — with specific data on 85% labor reductions and 1 ton of CO2e saved annually.
-
Lessons From FDA 483s And Warning Letters: Cleanroom Compliance12/8/2025
Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.
QUALITY CONTROL SOLUTIONS
-
Discover how Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.
-
The United States Pharmacopeia USP 1207 guidance has been revised, encouraging the preference to deterministic, quantitative, and reliable non-destructive technologies to comply with quality standards.
-
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
Learn about a custom chemical bulk packaging service that offers high-purity raw materials in precise amounts in a variety of ready-to-use configurations for cGMP manufacturers.
-
Explore end-to-end solutions and products suited to your organization, whether for research and discovery or planning for scale to commercial manufacturing.